Zupituss
Zupituss Syrup
(Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine Hydrochloride 20 mg)
Zupituss is a reliable anti-tussive formulation specifically designed to relieve non-productive cough in patients of all ages. With its unique dual mechanism of action, Zupituss provides effective cough suppression while ensuring excellent patient tolerability.
Key Ingredient:
Levocloperastine Hydrochloride (20 mg)
A well-established central & peripheral acting antitussive agent.
Unlike many cough suppressants, it not only works at the bulbar cough center in the brain but also acts on peripheral receptors in the tracheobronchial tree, providing broader and more effective relief.
Clinical Benefits & Action:
Dual mechanism of action – Works centrally and peripherally to suppress cough reflex effectively.
Effective in ACE-Inhibitor induced cough – Especially beneficial in hypertensive and cardiac patients who often experience persistent cough due to ACE inhibitors.
Rapid onset of action – Provides faster cough relief, improving patient comfort and quality of life.
Excellent tolerability – Safe and well-tolerated across all age groups, making it suitable for both adults and children.
Indications (Therapeutic Uses):
Cough associated with acute respiratory conditions (e.g., viral infections, acute bronchitis).
Cough associated with chronic respiratory diseases (e.g., COPD, chronic bronchitis, asthma-related cough).
Non-productive cough of varying etiologies.
ACE-Inhibitor induced cough in hypertensive patients.
Advantages of Zupituss:
Provides sure relief in non-productive cough without excessive sedation.
Safe for long-term use in chronic conditions.
More effective compared to traditional cough suppressants due to dual action mechanism.
💊 Zupituss – The trusted anti-tussive agent for effective relief in non-productive cough.
